Thomas Daix
Overview
Explore the profile of Thomas Daix including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
686
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lafon T, Jeannet R, Daix T, Monneret G, Feuillard J
Cytometry B Clin Cytom
. 2025 Mar;
PMID: 40065588
Anticipating the evolution of septic patients with community-acquired pneumonia (CAP) is challenging for front-line physicians in the Emergency Department (ED). Prognosis depends mainly on early identification, antibiotics, organ support, but...
2.
Shankar-Hari M, Francois B, Remy K, Gutierrez C, Pastores S, Daix T, et al.
JCI Insight
. 2025 Feb;
PMID: 39903535
Background: Lymphopenia and failure of lymphocytes to mount an early IFN-γ response correlate with increased mortality in COVID-19. Given the essential role of CD4 helper and CD8 cytotoxic cells in...
3.
Nardot A, Lacorre C, Lanneluc A, Paulet D, Gauriat M, Moesch C, et al.
Intern Emerg Med
. 2025 Jan;
PMID: 39888482
Implementation of a regional sepsis program to improve compliance with sepsis care bundles and optimize septic patient management and outcomes in the Emergency Department (ED). The program included a multifaceted...
4.
Deye N, Le Gouge A, Francois B, Chenevier-Gobeaux C, Daix T, Merdji H, et al.
Crit Care Explor
. 2024 Jul;
6(7):e1104.
PMID: 38957212
Importance: Ventilator-associated pneumonia (VAP) frequently occurs in patients with cardiac arrest. Diagnosis of VAP after cardiac arrest remains challenging, while the use of current biomarkers such as C-reactive protein (CRP)...
5.
de Prost N, Audureau E, Guillon A, Handala L, Preau S, Guigon A, et al.
Ann Intensive Care
. 2024 Jun;
14(1):101.
PMID: 38940865
Background: A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However,...
6.
Bay P, Audureau E, Preau S, Favory R, Guigon A, Heming N, et al.
Ann Intensive Care
. 2024 Jun;
14(1):87.
PMID: 38874854
No abstract available.
7.
Chollet S, Hernandez Padilla A, Daix T, Gaschet M, Francois B, Piguet C, et al.
iScience
. 2024 May;
27(6):109825.
PMID: 38799552
Septic patients with worst clinical prognosis have increased circulating immature granulocytes (IG), displaying limited phagocytosis and reactive oxygen species (ROS) production. Here, we developed an model of incubation of human...
8.
Bay P, Audureau E, Preau S, Favory R, Guigon A, Heming N, et al.
Ann Intensive Care
. 2024 Apr;
14(1):65.
PMID: 38658426
Background: During the first COVID-19 pandemic wave, COVID-19-associated pulmonary aspergillosis (CAPA) has been reported in up to 11-28% of critically ill COVID-19 patients and associated with increased mortality. As new...
9.
Lafon T, Chapuis N, Guerin E, Daix T, Otranto M, Boumediene A, et al.
J Leukoc Biol
. 2024 Feb;
115(6):1131-1142.
PMID: 38366559
Because one-third of patients deteriorate after their admission to the emergency department, assessing the prognosis of COVID-19 patients is of great importance. However, to date, only lymphopenia and the partial...
10.
Vaidie J, Peju E, Jandeaux L, Lesouhaitier M, Lacherade J, Guillon A, et al.
Crit Care
. 2023 Sep;
27(1):340.
PMID: 37660107
Background: Except in a few retrospective studies mainly including patients under chemotherapy, information regarding the impact of immunosuppressive therapy on the prognosis of patients admitted to the intensive care unit...